TickerFacts.

Thermo Fisher Scientific Inc. (TMO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2009-12-31, 2010-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

$6.05B
Year ended 2018-12-31
+14.6%
3-year compound annual growth
+18.3%
5-year compound annual growth
2007-12-31: $1.73B2008-12-31: $2.02B2009-12-31: $1.76B2010-12-31: $1.93B2011-12-31: $2.11B2012-12-31: $2.47B2013-12-31: $2.61B2014-12-31: $4.19B2015-12-31: $4.02B2016-12-31: $4.22B2017-12-31: $4.99B2018-12-31: $6.05B$6.05B
2007-12-31 EBITDA (USD) 2018-12-31
Period endedEBITDAChange YoYSource filing
2018-12-31$6.05B+21.2%2021-02-25, From 2018-01-01
2017-12-31$4.99B+18.4%2020-02-26, From 2017-01-01
2016-12-31$4.22B+4.8%2019-02-27, From 2016-01-01
2015-12-31$4.02B-3.9%2018-02-28, From 2015-01-01
2014-12-31$4.19B+60.5%2017-02-28, From 2014-01-01
2013-12-31$2.61B+5.8%2016-02-25, From 2013-01-01
2012-12-31$2.47B+16.8%2015-02-26, From 2012-01-01
2011-12-31$2.11B+9.5%2014-02-27, From 2011-01-01
2010-12-31$1.93Bn/c2013-02-27, From 2010-01-01
2009-12-31$1.76Bn/c2012-02-29, From 2009-01-01
2008-12-31$2.02B+16.8%2011-02-24, From 2008-01-01
2007-12-31$1.73Bn/a2010-02-26, From 2007-01-01